|
|
|
|
|
|
|
|
|
|
video
Dr. Amit Oza with an update from ECC 2013 on the final overall survival results in the GCIG phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer.
Saturday, November 16, 2013
ICON7 Trial Update - Dr. Amit Oza
video
Dr. Amit Oza with an update from ECC 2013 on the final overall survival results in the GCIG phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer.
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.